Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5115 Ulmerton Road, Clearwater, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
BOVIE MEDICAL CORP (to 1/2/2019), BOVIE MEDICAL Corp (to 1/2/2019), AN CON GENETICS INC (to 1/13/1999)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 554 % +66.6%
Quick Ratio 87.5 % +15.5%
Debt-to-equity 278 % +364%
Return On Equity -155 % -269%
Return On Assets -41.2 % -56.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.6M shares 0%
Common Stock, Shares, Outstanding 34.6M shares 0%
Entity Public Float 168M USD -16.9%
Common Stock, Value, Issued 35K USD 0%
Weighted Average Number of Shares Outstanding, Basic 34.6M shares +0.01%
Weighted Average Number of Shares Outstanding, Diluted 34.6M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 48.5M USD -3.49%
Research and Development Expense 4.77M USD -9.86%
Operating Income (Loss) -21.6M USD -23.9%
Nonoperating Income (Expense) -1.03M USD -189%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28.3M USD -60.1%
Income Tax Expense (Benefit) 250K USD
Net Income (Loss) Attributable to Parent -28.4M USD -87.7%
Earnings Per Share, Basic -0.83 USD/shares -93%
Earnings Per Share, Diluted -0.82 USD/shares -74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28M USD +26.6%
Accounts Receivable, after Allowance for Credit Loss, Current 13M USD +3.07%
Inventory, Net 9M USD -20.2%
Assets, Current 52.2M USD +4%
Property, Plant and Equipment, Net 1.91M USD -8.98%
Operating Lease, Right-of-Use Asset 4.82M USD -8.61%
Other Assets, Noncurrent 1.79M USD -3.77%
Assets 60.7M USD +2.15%
Accounts Payable, Current 1.91M USD -6.63%
Employee-related Liabilities, Current 1.28M USD
Accrued Liabilities, Current 7.29M USD
Contract with Customer, Liability, Current 515K USD -51.1%
Liabilities, Current 9.56M USD -7.18%
Contract with Customer, Liability, Noncurrent 1.27M USD -4.15%
Operating Lease, Liability, Noncurrent 4.61M USD -7.73%
Other Liabilities, Noncurrent 201K USD +11.1%
Liabilities 49.5M USD +91.5%
Retained Earnings (Accumulated Deficit) -73.3M USD -63.4%
Stockholders' Equity Attributable to Parent 11M USD -66.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.2M USD -66.7%
Liabilities and Equity 60.7M USD +2.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.34M USD -237%
Net Cash Provided by (Used in) Financing Activities -5K USD -100%
Net Cash Provided by (Used in) Investing Activities -35K USD +68.2%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 34.6M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.37M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.7M USD +76.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +117400%
Deferred Tax Assets, Valuation Allowance 16.4M USD +36.3%
Deferred Tax Assets, Gross 18M USD +44%
Operating Lease, Liability 5.24M USD +664%
Payments to Acquire Property, Plant, and Equipment 35K USD -68.2%
Lessee, Operating Lease, Liability, to be Paid 7.79M USD +987%
Property, Plant and Equipment, Gross 5.04M USD -55.4%
Operating Lease, Liability, Current 330K USD +6.45%
Lessee, Operating Lease, Liability, to be Paid, Year Two 805K USD +560%
Lessee, Operating Lease, Liability, to be Paid, Year One 778K USD +240%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +236%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.55M USD +8119%
Lessee, Operating Lease, Liability, to be Paid, Year Three 832K USD +582%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 860K USD +605%
Additional Paid in Capital 84.3M USD +7.85%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 157K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 1.59M USD +248%
Share-based Payment Arrangement, Expense 4.09M USD -30%
Interest Expense 4.52M USD +479%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%